Emerging Infectious Diseases (May 2013)

Treatment of Tularemia in Patient with Chronic Graft-versus-Host Disease

  • Jan Weile,
  • Erik Seibold,
  • Cornelius Knabbe,
  • Martin Kaufmann,
  • Wolf Splettstoesser

DOI
https://doi.org/10.3201/eid1905.120377
Journal volume & issue
Vol. 19, no. 5
pp. 771 – 773

Abstract

Read online

We describe a case of human tularemia caused by Francisella tularensis subsp. holarctica in a stem cell transplant recipient with chronic graft-versus-host disease who was receiving levofloxacin prophylaxis. The infection was characterized by pneumonia with septic complications. The patient was successfully treated with doxycycline.

Keywords